Benitec Biopharma (BNTC) Current Assets (2019 - 2025)
Benitec Biopharma (BNTC) has disclosed Current Assets for 7 consecutive years, with $104.0 million as the latest value for Q1 2025.
- Quarterly Current Assets rose 624.0% to $104.0 million in Q1 2025 from the year-ago period, while the trailing twelve-month figure was $104.0 million through Mar 2025, up 624.0% year-over-year, with the annual reading at $51.7 million for FY2024, 1285.73% up from the prior year.
- Current Assets hit $104.0 million in Q1 2025 for Benitec Biopharma, up from $68.3 million in the prior quarter.
- In the past five years, Current Assets ranged from a high of $104.0 million in Q1 2025 to a low of $3.7 million in Q2 2023.
- Historically, Current Assets has averaged $25.0 million across 5 years, with a median of $15.4 million in 2021.
- Biggest five-year swings in Current Assets: tumbled 76.61% in 2022 and later surged 1285.73% in 2024.
- Year by year, Current Assets stood at $12.7 million in 2021, then fell by 13.39% to $11.0 million in 2022, then skyrocketed by 89.49% to $20.8 million in 2023, then skyrocketed by 228.6% to $68.3 million in 2024, then skyrocketed by 52.21% to $104.0 million in 2025.
- Business Quant data shows Current Assets for BNTC at $104.0 million in Q1 2025, $68.3 million in Q3 2024, and $51.7 million in Q2 2024.